Good News for Humankind Your daily spark of possibility
The world is changing — for the better, and in real, indisputable ways. Climate breakthroughs. Justice wins. Scientific discoveries. From people you’ve never heard of. In places you wouldn’t expect.
Every weekday, I send a piece of good news from around the world — not to sugarcoat reality, but to remind you that change is possible.
Every weekday morning at 7am. Or sign up for the weekly digest.
What Readers Are Saying
It restores my faith that homo sapiens sapiens, even if not in everything and always, deserves the name it has given itself.
Peter is all passion. He’s spent years working toward the greater good by helping his readership and community becoming the best version of themselves. His thoughtfully curated positive news stories stem from his genuine and effortless capacity to empathize. You’re an inspiration, Peter. Thank you!
Good News daily restores my faith in humanity and in Universal Source; I’ve shared this newsletter with family and friends and we love it! Hurray for Peter’s inspiration and generosity! So grateful.
I forward this to friends who need a remedy for despair.
Good News for Humankind has been a crack of light in my inbox for years
The Latest Good News
Topic All #Resist Abortion rights & access Activism & Protests Agriculture Air pollution Animal husbandry & domestication Animal rights & well-being Architecture & design Artificial intelligence Arts, music, literature & entertainment Astronomy & space exploration Athletics & sport Black Lives Matter Blockchain & cryptocurrency Capital punishment Caste abolition Child well-being Circular economy & zero waste Cities Civilization Clean & renewable energy Climate crisis Clothing Colonialism Communication & language Conscious management Consumer rights & well-being Corporate responsibility COVID-19 Crime Culture Death & Grief Debt Decolonization Democracy & voting Disabilities & special needs Discovery & exploration Drinking water; sanitation & hygiene Drugs & Entheogens Economic inequality Education Elections Electrification Environment Ethical sourcing Ethics Evolution Finance Flora & fauna Food & diet Free speech & censorship Fresh water conservation Gay rights Gender Genocide Government Green bonds Gun safety Hate speech Healthcare Houselessness Human rights Immigration Independence Indigenous rights & well-being Infrastructure International cooperation Internet rights Journalism Justice system Kingdoms & empire Law LGBTQ+ rights & well-being Life expectancy & mortality Literature Local resilience Marine conservation Medicine Men's health & well-being Mental health & addiction Migration & settlement Military Mindfulness & self-care Minimum wage Mythology & folklore Nations Natural gas & divestment News & media No coal No fracking Nuclear disarmament Numbers & math Ocean health Oil Oil, natural gas & divestment Parenting Paris Agreement Peace Philanthropy Philosophy Physics Plastic pollution Police reform Pollution Poverty alleviation Prison justice Privacy & security Public health & disease Public safety Racial justice Refugees Religion Reparations Reproductive rights Revolution Rights of nature Same-sex marriage Seniors' rights & well-being Sexual assault & domestic violence Shamanism & rituals Social media Sustainability Sustainable Development Goals Technology & innovation Tourism Trade Transgender rights & well-being Transportation Trees & reforestation Universal basic income Water pollution Wildlife & land conservation Women's rights & well-being Workers' rights & well-being Youth & student movements
Country All Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bangladesh Barbados Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia-Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Chad Cherokee Nation Chile China Colombia Congo Cook Islands Costa Rica Croatia Cuba Cyprus Czech Republic Democratic Republic of Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador England Equatorial Guinea Eritrea Estonia Ethiopia European Union Faroe Islands Federated States of Micronesia Fiji Finland France French Polynesia Gabon Georgia Germany Ghana Greece Greenland Grenada Guadaloupe Guatemala Guyana Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal New Caledonia New Zealand / Aotearoa Nicaragua Niger Nigeria Niue North Korea North Macedonia Northern Ireland Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Poland Portugal Qatar Romania Russia Rwanda Samoa San Marino Sao Tome and Principe Saudi Arabia Scotland Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South America South Korea South Sudan Soviet Union Spain Sri Lanka St. Kitts & Nevis St. Lucia St. Vincent and the Grenadines Sudan Suriname Sweden Switzerland Syria Taiwan Tanzania Thailand The Bahamas The Gambia The Netherlands The Philippines Timor Leste Togo Tokelau Tonga Trinidad & Tobago Tristan da Cunha Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wales Yemen Zambia Zimbabwe
Actor All Activists Artists & philosophers Athletes Business Cities Citizens Civil society Consumers Courts Early humans Engineers Finance Humanity Humankind Indigenous groups International organizations Inventors Kingdoms & empires Media & Journalists Military Nations Non-humans Regions Religious groups Science & academia Scientists & mathematicians Settlers & explorers States & provinces Utilities Workers World leaders
2023 C.E.
May 3 Japan's first abortion pill won approval in 2023, and clinical trials there showed 93% of participants had a complete abortion within 24 hours using the two-pill combination. Until that vote, Japan had been one of the last developed nations offering only surgical options, including a method the World Health Organization calls obsolete. The ministry took the unusual step of opening a public comment period before deciding, drawing strong responses from doctors and advocates who...
2023 C.E.
May 2 Women voted at the Vatican's Synod of Bishops for the first time in October 2023, after Pope Francis rewrote the rules to seat them as full participants. Five religious sisters joined five priests as voting representatives for religious orders, and Francis appointed 70 non-bishop members to the synod, asking that half be women. The meeting itself grew out of a two-year listening process that gathered the hopes of lay Catholics across dozens of countries...
2023 C.E.
April 26 Electric vehicles are on track to hit 14 million global sales in 2023, up from 10 million the year before — a jump that has analysts revising their forecasts upward yet again. The International Energy Agency now expects EVs to make up 35 percent of new car sales worldwide by 2030, a sharp leap from the 21 percent it predicted just one year earlier. The shift is showing up in unexpected places too: in...
2023 C.E.
April 25 New Zealand's cabinet reached gender parity for the first time ever, with women and men now sharing the top table 10-10. The shift came when Prime Minister Chris Hipkins promoted Willow-Jean Prime, who holds the conservation and youth portfolios, bringing the number of Māori ministers in cabinet to a record six. Counting ministers outside cabinet too, women now outnumber men across the full ministerial ranks — a quieter milestone that may matter even more....
2023 C.E.
April 17 Ghana's approval of the R21 malaria vaccine — the first anywhere in the world — clears the way for children as young as five months to be protected against a disease that kills roughly 620,000 people every year, mostly young kids in Africa. Developed at Oxford's Jenner Institute, R21 showed up to 80% effectiveness in early trials and is expected to cost just a couple of dollars per dose. The Serum Institute of India...
Load More
Enjoying these stories? Get one delivered to your inbox every weekday morning — free.
Go to good news archives for specific countries, institutions, topics, etc.
